Alice Y Zhou

9PUBLICATIONS
87CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 26, 2026
Circulating Tumor DNA (ctDNA) Clearance After Immune Checkpoint Inhibition (ICI) with Radiotherapy (RT) as a Prognostic Biomarker for Advanced Melanoma.

|Mar 25, 2026
NT-I7, a Long-Acting Interleukin 7, Increases Lymphocyte Counts and Induces CD8+ T-cell Clonotype Expansion in Patients with Newly Diagnosed High-Grade Gliomas.

Omar H Butt, Kartik Singhal, Jingqin Luo

|Feb 13, 2026
Multi-Institutional Study Evaluating the Role of Early Circulating Tumor DNA Dynamics During Treatment With Immune Checkpoint Inhibitors in Patients With Advanced-Stage Melanoma.

Vincent T Ma, Alice Y Zhou, Amir Forati

|Jan 14, 2026
Homologous Recombination Deficiency in Skin Cancers: Prevalence and Clinical Implications of This Distinct Patient Cohort.

George Nassief, Tolulope Adeyelu, Andrew Elliott

|Mar 12, 2025
Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myeloma.

Alice Y Zhou, Nancy D Marin, Sadia Afrin

|Jun 28, 2024
Cytokines drive the formation of memory-like NK cell subsets via epigenetic rewiring and transcriptional regulation.

Jennifer A Foltz, Jennifer Tran, Pamela Wong

Pageof 2

Frequent Collaborators

5 joint publications

Jennifer A Foltz

4 joint publications

Nancy D Marin

4 joint publications

Pamela Wong

4 joint publications

Celia C Cubitt